Chimerix Inc (CMRX)

Currency in USD
8.540
0.000(0.00%)
Closed·
CMRX Scorecard
Full Analysis
Does not pay a dividend to shareholders
Showing Chimerix historical data. For real-time data please try another search
Day's Range
8.5408.550
52 wk Range
0.7508.550
Key Statistics
Prev. Close
8.54
Open
8.55
Day's Range
8.54-8.55
52 wk Range
0.75-8.55
Volume
-
Average Volume (3m)
4.22M
1-Year Change
938.93%
Book Value / Share
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
CMRX Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Does not pay a dividend to shareholders

Chimerix Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Neutral

Chimerix Inc Company Profile

Chimerix, Inc. develops medicines to improve and extend the lives of patients facing deadly diseases in the United States. Its product pipeline comprises dordaviprone (ONC201), which is in phase 3 clinical-stage development for H3 K27M-mutant diffuse glioma, as well as in phase 2 Investigator Initiated Clinical Trials for multiple oncology studies; and ONC206, a second generation imipridone ClpP agonist and DRD2 antagonist which is in phase 1 clinical trial to treat central nervous systems and other solid tumors. The company also develops ONC212, an imipridone, an investigational agonist of the orphan GPCR tumor suppressor GPR132, as well as ClpP, which is in preclinical trials; and CMX521, a nucleoside analog antiviral drug candidate for the treatment of novel coronaviruses. In addition, it offers TEMBEXA, a lipid conjugate which acts via inhibition of viral DNA synthesis, which is a medical countermeasure for smallpox. The company was incorporated in 2000 and is based in Durham, North Carolina. As of April 21, 2025, Chimerix, Inc. operates as a subsidiary of Jazz Pharmaceuticals plc.

Compare CMRX to Peers and Sector

Metrics to compare
CMRX
Peers
Sector
Relationship
P/E Ratio
0.0x0.0x0.0x
PEG Ratio
0.000.000.00
Price/Book
0.0x0.0x0.0x
Price / LTM Sales
0.0x0.0x0.0x
Upside (Analyst Target)
0.0%0.0%0.0%
Fair Value Upside
Unlock0.0%0.0%Unlock

Earnings

Latest Release
May 01, 2025
EPS / Forecast
-- / -0.2667
Revenue / Forecast
-- / 100.00K
EPS Revisions
Last 90 days

CMRX Income Statement

People Also Watch

12.970
REP
-2.33%
41.130
ITX
-1.86%
586.44
NOC
+1.70%
52.460
ASTS
-1.34%
17.140
SBET
-8.88%
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.